
Podcast
Perfect Storm for US Drug Manufacturing as FDA Changes, Trade Wars and M&A Surge Collide
“There’s optimism… but the challenges aren’t day to day – it can be minute to minute,” warns Gil Roth, President of the Pharma and Biopharma Outsourcing Association (PBOA), describing a pharmaceutical manufacturing sector facing unprecedented change in 2025. Gil Roth